In Vivo Pharmacodynamic Evaluation of B-Tg(Luc)A549 (mix) Cells Induced Lung Cancer Models (CAT#: STEM-AE-0652-LGZ)

Introduction

Cancer type: Lung cancer
Cell line: B-Tg(Luc)A549 (mix)
Clone: mix clone
Inoculation: i.V.

Principle Applications Procedure Materials Notes Related Products

Principle

By seeding tumor cells at organ-specific sites of the original tumor, in situ models simulate the initial lesion and establish better tumor, stroma, and immune component interactions than subcutaneous implants.

Applications

Lung Cancer

Procedure

1. Disease model construction.
2. Mice dosing.
3. Efficacy monitoring.
4. Biochemical detection of tissue samples.

Materials

• Sample Type: liquid or powder

Other recommended products

In Vivo Pharmacodynamic Evaluation of B-hNPR1 Mice (Humanized Mice) (CAT#: STEM-AE-0634-LGZ)
In Vivo Pharmacodynamic Evaluation of B-hDLL3 Mice (Humanized Mice) (CAT#: STEM-AE-0633-LGZ)
In Vivo Pharmacodynamic Evaluation of B-hCCR4 Mice (GPCR Humanized Mice) (CAT#: STEM-AE-0565-LGZ)
In Vivo Pharmacodynamic Evaluation of KATOIII Cell Line Based Gastric Cancer (CAT#: STEM-AE-0054-LGZ)
In Vivo Pharmacodynamic Evaluation of SJSA-1 Cell Line Based Bone Cancer (CAT#: STEM-AE-0004-LGZ)
In Vivo Pharmacodynamic Evaluation of B-hPD-1/hPD-L1/hIL1B Mice (Cytokine Humanized Mice) (CAT#: STEM-AE-0537-LGZ)
In Vivo Pharmacodynamic Evaluation of B-hMERTK Mice (Immune Checkpoint Humanized Mice) (CAT#: STEM-AE-0301-LGZ)
In Vivo Pharmacodynamic Evaluation of B-hITGB7 Mice (Humanized Mice) (CAT#: STEM-AE-0630-LGZ)